Moody National Bank Trust Division’s Biogen BIIB Stock Holding History

Moody National Bank Trust Division’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,485	Closed	-$382K	–	508
2023 Q3	$382K	Buy	1,485 +54	+4%	+$14.4K	0.02%	452
2023 Q2	$408K	Hold	1,431	–	–	0.03%	437
2023 Q1	$398K	Hold	1,431	–	–	0.03%	433
2022 Q4	$396K	Hold	1,431	–	–	0.03%	411
2022 Q3	$382K	Buy	1,431 +59	+4%	+$12.5K	0.04%	392
2022 Q2	$280K	Buy	+1,372	New	+$280K	0.03%	429
2019 Q2	–	Sell	-136	Closed	-$32K	–	434
2019 Q1	$32K	Hold	136	–	–	﹤0.01%	468
2018 Q4	$41K	Buy	+136	New	+$43.4K	﹤0.01%	415

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Moody National Bank Trust Division's BIIB Position: Q4 2023 in Review

Moody National Bank Trust Division sold out of Biogen (BIIB) in Q4 2023, closing a stake of 1,485 shares — an estimated $382K sold.

Moody National Bank Trust Division first reported a position in BIIB in Q4 2018 and held it in 8 quarters. The position peaked at $408K in Q2 2023. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q4 2023.

Moody National Bank Trust Division reported no remaining Biogen position as of Q4 2023 after selling out during the quarter.
Moody National Bank Trust Division sold 1,485 Biogen shares in Q4 2023, an estimated $382K.
Moody National Bank Trust Division first reported a position in Biogen in Q4 2018 and held it in 8 quarters.
Moody National Bank Trust Division's Biogen position peaked at $408K in Q2 2023.
1,003 funds tracked by Wall St. Rank held Biogen as of Q4 2023.

Based on Moody National Bank Trust Division's 13F filing for Q4 2023, filed 11 Jan 2024.